Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2026-01-26 @ 2:54 AM
Study NCT ID:
NCT02345161
Status:
COMPLETED
Last Update Posted:
2018-07-13
First Post:
2015-01-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-23
Start Date Type:
None
Primary Completion Date:
2016-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-07
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-19
First Submit QC Date:
None
Study First Post Date:
2015-01-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-05
Results First Submit QC Date:
None
Results First Post Date:
2018-07-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-26
Last Update Post Date:
2018-07-13
Last Update Post Date Type:
ACTUAL